Novel antineoplastic agents.
Bukowski
R M
RM
Experimental Therapeutics Program, Cleveland Clinic Cancer Center, S33, 9500 Euclid Avenue, Cleveland, OH 441195, USA.
D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002453:Cell Cycle / Q000187:drug effects; D004333:Drug Administration Routes; D006133:Growth Substances; D006801:Humans; D007155:Immunologic Factors; D008967:Molecular Biology / Q000639:trends; D009369:Neoplasms / Q000188:drug therapy; D009857:Oncogenes; D015398:Signal Transduction
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D006133:Growth Substances; D007155:Immunologic Factors